Patent ID: 8148069
Filing Date: 2012-04-03
Classification: A61K,A61P,C12N,C12Q

Abstract:
1. A method of diagnosing whether a subject has a solid cancer, comprising measuring in a test sample from the subject a level of miR-21 gene product and miR-191 gene product, comparing the level of the miR-21 gene product and miR-191 gene product in the test sample to a control level of miR-21 gene product and miR-191 gene product; and diagnosing whether a subject has a solid cancer selected from the group consisting of colon, lung, pancreas, prostate, and stomach cancer, wherein an increase in the level of miR-21 gene product and miR-191 gene product in the test sample, relative to the control level of miR-21 gene product and miR-191 gene product, is indicative of the subject having a solid cancer selected from the group consisting of colon, lung, pancreas, prostate, and stomach cancer.